B-cell enrichment predictive of immunotherapy response in melanoma, sarcoma and kidney cancer
The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell clusters known as tertiary lymphoid structures (TLS), according to researchers at The University of Texas MD Anderson Cancer Center.
Studies published today in Nature conclude that enrichment of B cells, a type of immune cell known for producing antibodies, in TLS was predictive of response...
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas
A study at The University of Texas MD Anderson Cancer Center demonstrated a potential new approach to treating two of the most common subtypes...